$NLNK Headlines 9 IPOs on tap; Angie's List, D
Post# of 94281
Posted On: 08/15/2014 1:16:27 PM
$NLNK Headlines
9 IPOs on tap; Angie's List, Delphi lead 2:11 p.m. Nov. 12, 2011 - MarketWatch.com
Ebola vaccine trials are a top priority for medical authorities 1:20 p.m. Aug. 14, 2014 - Seeking Alpha
Why NewLink Genetics (NLNK) Stock Is Gaining Today 11:31 a.m. Aug. 14, 2014 - TheStreet.com
Cel-Sci Is A Leader In The I-O Class Of Cancer Therapies 10:43 a.m. Aug. 12, 2014 - Seeking Alpha
Why A Short Covering Rally Might Come for NewLink Genetics (NLNK) Stock - Tale of the Tape 9:38 a.m. Aug. 7, 2014 - Zacks.com
Sarepta Should Shut Up About Ebola, Focus on Job No. 1 12:07 p.m. Aug. 6, 2014 - TheStreet.com
10-Q: NEWLINK GENETICS CORP 4:50 p.m. Aug. 5, 2014 - Edgar Online - (EDG = 10Q, 10K)
NewLink gets $1M Ebola study contract 8:14 a.m. Aug. 5, 2014 - Seeking Alpha
NewLink (NLNK) Shares March Higher, Can It Continue? - Tale of the Tape 9:35 a.m. July 2, 2014 - Zacks.com
NewLink immunotherapeutic improves survival in pancreatic cancer 9:03 a.m. June 2, 2014 - Seeking Alpha
Encouraging data from NewLink immunotherapeutic study 8:18 a.m. May 30, 2014 - Seeking Alpha
NewLink Genetics (NLNK) Shares Cross Above 200 DMA 4:32 p.m. May 9, 2014 - TheStreet.com
10-Q: NEWLINK GENETICS CORP 2:24 p.m. May 8, 2014 - Edgar Online - (EDG = 10Q, 10K)
NewLink Genetics Q1 results 7:28 a.m. May 6, 2014 - Seeking Alpha
Don't Get Dazzled by Glittering Growth 5:38 p.m. April 11, 2014 - The Wall Street Journal Interactive Edition
NewLink Genetics' CEO Discusses Q4 2013 Results - Earnings Call Transcript 6:34 p.m. March 12, 2014 - Seeking Alpha
10-K: NEWLINK GENETICS CORP 4:56 p.m. March 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
Biotech Stock Roundup: Amgen, Regeneron Slide on PCSK9 Inhibitor Concerns - Analyst Blog 10:50 a.m. March 12, 2014 - Zacks.com
NewLink Genetics' Shares Sink - Analyst Blog 1:36 p.m. March 10, 2014 - Zacks.com
NewLink down 10% premarket 9:20 a.m. March 7, 2014 - Seeking Alpha
Is It Too Late to Buy the Rally in Small Caps? 1:00 a.m. March 7, 2014 - InvestorPlace.com
Small companies lead the I-O class of Cancer Therapies 8:03 a.m. Aug. 8, 2014 - ACCESSWIRE
NewLink Genetics Corporation, Through Its Wholly Owned Subsidiary, BioProtection Systems Corporation, Secures a Letter Contract From the Defense Threat Reduction Agency for Testing and Evaluation of Ebola Virus Vaccine 7:16 a.m. Aug. 5, 2014 - Marketwire
NewLink Genetics Corporation Reports Second Quarter 2014 Financial Results 7:16 a.m. Aug. 5, 2014 - Marketwire
NewLink Genetics to Present at the XVIth International Congress of Virology 7:15 a.m. July 28, 2014 - Marketwire
Biotech Equities Ahead of Market -- Research on Vertex Pharma, NewLink Genetics, ImmunoGen, and Synta Pharma 7:20 a.m. June 5, 2014 - PR Newswire - PRF
NewLink Genetics Demonstrates Continuing IDO Pathway Inhibitor Progress at ASCO 2014 Annual Meeting 2:35 a.m. June 5, 2014 - Marketwire
NewLink Genetics Dorgenmeltucel-L HyperAcute Immunotherapy for Melanoma Demonstrates Clinical Efficacy With Tumor Regression and Immune Activation 7:11 a.m. May 30, 2014 - Marketwire
NewLink Genetics to Present at Jefferies 2014 Global Healthcare Conference 4:46 p.m. May 29, 2014 - Marketwire
NewLink Genetics to Present at the ASCO 2014 Annual Meeting 7:16 a.m. May 15, 2014 - Marketwire
NewLink Genetics Corporation Reports First Quarter 2014 Financial Results 6:05 a.m. May 7, 2014 - Marketwire
Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant 1:21 p.m. April 23, 2014 - PR Newswire - PRF
NewLink Genetics Presents Data at the AACR 2014 Annual Meeting 11:16 a.m. April 9, 2014 - Marketwire
NewLink Genetics to Present Data at the AACR 2014 Annual Meeting 7:16 a.m. March 25, 2014 - Marketwire
Financial Results, Clinical Study Updates, Clinical Trial Results, Business Spin-Offs, and New Joint Ventures - Analyst Notes on ARIAD, NewLink, Puma Biotechnology, Theravance, and Ohr Pharmaceutical 8:00 a.m. March 12, 2014 - PR Newswire - PRF
NewLink Genetics' Independent Review Committee Recommends Study Continuation Without Modification After Completion of First Interim Analysis of IMPRESS Phase 3 Pancreatic Cancer Trial With Algenpantucel-L 8:16 a.m. March 7, 2014 - Marketwire
NewLink Genetics Appoints Eugene P. Kennedy, M.D., as Vice President for Clinical and Medical Affairs 10:16 a.m. Feb. 26, 2014 - Marketwire
NewLink Genetics to Present at 2014 Leerink Global Healthcare Conference 8:15 a.m. Feb. 11, 2014 - Marketwire
CEL-SCI Corporation Analyst Report 8:00 a.m. Jan. 27, 2014 - PR Newswire - PRF
Mentor Capital Cancer Immunotherapy Index Up 97% in 2013 12:02 p.m. Jan. 21, 2014 - BusinessWire - BZX
Additional Analyses Results, Stock Price Updates, Products & Services Deployment, and Proposed Public Offerings - Research Report on CytRx, Intrexon, Allscripts, Acceleron, and NewLink 9:00 a.m. Jan. 15, 2014 - PR Newswire - PRF
9 IPOs on tap; Angie's List, Delphi lead 2:11 p.m. Nov. 12, 2011 - MarketWatch.com
Ebola vaccine trials are a top priority for medical authorities 1:20 p.m. Aug. 14, 2014 - Seeking Alpha
Why NewLink Genetics (NLNK) Stock Is Gaining Today 11:31 a.m. Aug. 14, 2014 - TheStreet.com
Cel-Sci Is A Leader In The I-O Class Of Cancer Therapies 10:43 a.m. Aug. 12, 2014 - Seeking Alpha
Why A Short Covering Rally Might Come for NewLink Genetics (NLNK) Stock - Tale of the Tape 9:38 a.m. Aug. 7, 2014 - Zacks.com
Sarepta Should Shut Up About Ebola, Focus on Job No. 1 12:07 p.m. Aug. 6, 2014 - TheStreet.com
10-Q: NEWLINK GENETICS CORP 4:50 p.m. Aug. 5, 2014 - Edgar Online - (EDG = 10Q, 10K)
NewLink gets $1M Ebola study contract 8:14 a.m. Aug. 5, 2014 - Seeking Alpha
NewLink (NLNK) Shares March Higher, Can It Continue? - Tale of the Tape 9:35 a.m. July 2, 2014 - Zacks.com
NewLink immunotherapeutic improves survival in pancreatic cancer 9:03 a.m. June 2, 2014 - Seeking Alpha
Encouraging data from NewLink immunotherapeutic study 8:18 a.m. May 30, 2014 - Seeking Alpha
NewLink Genetics (NLNK) Shares Cross Above 200 DMA 4:32 p.m. May 9, 2014 - TheStreet.com
10-Q: NEWLINK GENETICS CORP 2:24 p.m. May 8, 2014 - Edgar Online - (EDG = 10Q, 10K)
NewLink Genetics Q1 results 7:28 a.m. May 6, 2014 - Seeking Alpha
Don't Get Dazzled by Glittering Growth 5:38 p.m. April 11, 2014 - The Wall Street Journal Interactive Edition
NewLink Genetics' CEO Discusses Q4 2013 Results - Earnings Call Transcript 6:34 p.m. March 12, 2014 - Seeking Alpha
10-K: NEWLINK GENETICS CORP 4:56 p.m. March 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
Biotech Stock Roundup: Amgen, Regeneron Slide on PCSK9 Inhibitor Concerns - Analyst Blog 10:50 a.m. March 12, 2014 - Zacks.com
NewLink Genetics' Shares Sink - Analyst Blog 1:36 p.m. March 10, 2014 - Zacks.com
NewLink down 10% premarket 9:20 a.m. March 7, 2014 - Seeking Alpha
Is It Too Late to Buy the Rally in Small Caps? 1:00 a.m. March 7, 2014 - InvestorPlace.com
Small companies lead the I-O class of Cancer Therapies 8:03 a.m. Aug. 8, 2014 - ACCESSWIRE
NewLink Genetics Corporation, Through Its Wholly Owned Subsidiary, BioProtection Systems Corporation, Secures a Letter Contract From the Defense Threat Reduction Agency for Testing and Evaluation of Ebola Virus Vaccine 7:16 a.m. Aug. 5, 2014 - Marketwire
NewLink Genetics Corporation Reports Second Quarter 2014 Financial Results 7:16 a.m. Aug. 5, 2014 - Marketwire
NewLink Genetics to Present at the XVIth International Congress of Virology 7:15 a.m. July 28, 2014 - Marketwire
Biotech Equities Ahead of Market -- Research on Vertex Pharma, NewLink Genetics, ImmunoGen, and Synta Pharma 7:20 a.m. June 5, 2014 - PR Newswire - PRF
NewLink Genetics Demonstrates Continuing IDO Pathway Inhibitor Progress at ASCO 2014 Annual Meeting 2:35 a.m. June 5, 2014 - Marketwire
NewLink Genetics Dorgenmeltucel-L HyperAcute Immunotherapy for Melanoma Demonstrates Clinical Efficacy With Tumor Regression and Immune Activation 7:11 a.m. May 30, 2014 - Marketwire
NewLink Genetics to Present at Jefferies 2014 Global Healthcare Conference 4:46 p.m. May 29, 2014 - Marketwire
NewLink Genetics to Present at the ASCO 2014 Annual Meeting 7:16 a.m. May 15, 2014 - Marketwire
NewLink Genetics Corporation Reports First Quarter 2014 Financial Results 6:05 a.m. May 7, 2014 - Marketwire
Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant 1:21 p.m. April 23, 2014 - PR Newswire - PRF
NewLink Genetics Presents Data at the AACR 2014 Annual Meeting 11:16 a.m. April 9, 2014 - Marketwire
NewLink Genetics to Present Data at the AACR 2014 Annual Meeting 7:16 a.m. March 25, 2014 - Marketwire
Financial Results, Clinical Study Updates, Clinical Trial Results, Business Spin-Offs, and New Joint Ventures - Analyst Notes on ARIAD, NewLink, Puma Biotechnology, Theravance, and Ohr Pharmaceutical 8:00 a.m. March 12, 2014 - PR Newswire - PRF
NewLink Genetics' Independent Review Committee Recommends Study Continuation Without Modification After Completion of First Interim Analysis of IMPRESS Phase 3 Pancreatic Cancer Trial With Algenpantucel-L 8:16 a.m. March 7, 2014 - Marketwire
NewLink Genetics Appoints Eugene P. Kennedy, M.D., as Vice President for Clinical and Medical Affairs 10:16 a.m. Feb. 26, 2014 - Marketwire
NewLink Genetics to Present at 2014 Leerink Global Healthcare Conference 8:15 a.m. Feb. 11, 2014 - Marketwire
CEL-SCI Corporation Analyst Report 8:00 a.m. Jan. 27, 2014 - PR Newswire - PRF
Mentor Capital Cancer Immunotherapy Index Up 97% in 2013 12:02 p.m. Jan. 21, 2014 - BusinessWire - BZX
Additional Analyses Results, Stock Price Updates, Products & Services Deployment, and Proposed Public Offerings - Research Report on CytRx, Intrexon, Allscripts, Acceleron, and NewLink 9:00 a.m. Jan. 15, 2014 - PR Newswire - PRF
(0)
(0)